[Experimental and clinical studies of an ampicillin suppository (KS-R1) in pediatrics].
Absorption of ampicillin (ABPC) suppository (KS-R1) was good with the peak level of ABPC at 15 minutes and the continuous high level for 1 hour by the administration of about 10 approximately 18 mg/kg. About 40% of active form of administered ABPC was excreted into urine within 6 hours. KS-R1 at the dose of about 20-40 mg/kg/day divided into 3-4 times was very against acute respiratory tract infection by the treatment for 3-5 days. The effective rate was 94% in 35 cases. By the administration of KS-R1, group A Streptococcus, S. pneumoniae and H. influenzae were eradicated. After the insertion of KS-R1, weak diarrhea and the discharge of KS-R1 were observed in 2 cases and 3 cases, respectively. It was concluded that KS-R1 is very useful drug for the treatment of infections by ABPC sensitive organisms in place of the oral form of ABPC.